Info
Significant Ownership

Significant Ownership of Sofinnova Venture Partners IX, L.P.

Signature - Title: /s/ Nathalie Auber - Nathalie Auber/Attorney-in-Fact
Location: Menlo Park, CA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Sofinnova Venture Partners IX, L.P..

Notify me when Sofinnova Venture Partners IX, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Sofinnova Venture Partners IX, L.P.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
NXTC	NextCure, Inc.	Common Stock, $0.001 par value	7.1%	$2,947,939		222,654		Sofinnova Venture Partners IX, L.P. ("SVP IX")	19 Dec 2025
AVBP	ArriVent Biopharma, Inc.	Common Stock, $0.0001 Par Value per Share	4.1%	$35,767,532		1,696,752		Sofinnova Venture Partners XI, L.P. ("SVP XI")	31 Dec 2025

Schedules 13D/G Reported by Sofinnova Venture Partners IX, L.P.:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.